Category: 374554-89-9

Application of 374554-89-9, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 374554-89-9, Name is 3-Chloro-6-fluorobenzo[d]isoxazole, molecular formula is C7H3ClFNO. In a Article£¬once mentioned of 374554-89-9

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists

Antagonists of the corticotropin-releasing factor (CRF) neuropeptide should prove to be effective in treating stress and anxiety-related disorders. In an effort to identify antagonists with improved physicochemical properties, new tricyclic CRF1 antagonists were designed, synthesized, and tested for biological activity. As a result of studies aimed at establishing a relationship between structure and CRF1 binding affinity, NBI 35965 (12a) was identified as a high-affinity antagonist with a pKi value of 8.5. Compound 12a proved to be a functional CRF1 antagonist with pIC50 values of 7.1 and 6.9 in the in vitro CRF-stimulated cAMP accumulation and ACTH production assays, respectively, and 12a also reduced CRF or stress induced ACTH production in vivo.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Application of 374554-89-9, you can also check out more blogs aboutApplication of 374554-89-9

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

Related Products of 374554-89-9, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 374554-89-9, name is 3-Chloro-6-fluorobenzo[d]isoxazole, introducing its new discovery.

Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions

A compound of formula (I) or a salt thereof: STR1 wherein: R1 is hydrogen, C1-6 alkyl or phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl; R2 is hydrogen or C1-6 alkyl; R3 is C2-10 alkenyl or C1-10 alkyl substituted by hydroxy, C1-4 alkoxy, thiol, C1-4 alkylthio or NR7 R8 wherein R7 and R8 are independently hydrogen or C1-6 alkyl or together are C3-6 polymethylene; R4 and R5 are independently hydrogen or C1-4 alkyl; and R6 is hydrogen; or C1-4 alkyl or benzyl attached at nitrogen atom 1 or 2; having anti-inflammatory and/or anti-allergy activity.

Related Products of 374554-89-9, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about Related Products of 374554-89-9

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

Application of 374554-89-9, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 374554-89-9, name is 3-Chloro-6-fluorobenzo[d]isoxazole, introducing its new discovery.

CRF RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

CRF receptor antagonists are disclosed which may have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a mammals, such as stroke. The CRF receptor antagonists of this invention have the following structure: and pharmaceutically acceptable salts, esters, solvates, stereoisomers and prodrugs thereof, wherein R1, R2n, R 5, Ar, and Het are as defined herein. Compositions containing a CRF receptor antagonist in combination with a pharmaceutically acceptable carrier are also disclosed, as well as methods for use of the same.

Application of 374554-89-9, Interested yet? Read on for other articles about Application of 374554-89-9!

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

374554-89-9, Name is 3-Chloro-6-fluorobenzo[d]isoxazole, belongs to Benzisoxazole compound, is a common compound. Quality Control of 3-Chloro-6-fluorobenzo[d]isoxazoleIn an article, once mentioned the new research about 374554-89-9.

Pyrazolopyridine derivatives and their use as anti-inflammatory and/or anti-allergic agents

Compounds of formula (I) and pharmaceutically acceptable salts thereof: STR1 wherein: R1 is hydrogen, C1-6 alkyl or phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl; R2 is hydrogen or C1-6 alkyl; R3 is hydroxy, nitro, cyano, C2-10 acyloxy, NR6 R7 wherein R6 and R7 are independently selected from hydrogen, C1-6 alkyl, C2-7 alkanoyl or C1-6 alkylsulphonyl; or COR8 wherein R8 is hydroxy, C1-6 alkoxy or NR9 R10 wherein R9 and R10 are independently selected from hydrogen or C1-6 alkyl; R4 is hydrogen, halogen, CF3, C1-4 alkoxy, C1-4 alkyl or any of the groups listed for R3 ; and R5 is hydrogen, C1-4 alkyl or benzyl optionally substituted in the phenyl ring by halogen, CF3, C1-4 alkoxy or C1-4 alkyl and is attached at nitrogen atom 1 or 2, having anti-inflammatory and/or anti-allergy activity, and their use as pharmaceuticals.

Quality Control of 3-Chloro-6-fluorobenzo[d]isoxazole, Each elementary reaction can be described in terms of its molecularity, the number of molecules that collide in that step. The slowest step in a reaction mechanism is the rate-determining step.you can also check out more blogs about Quality Control of 3-Chloro-6-fluorobenzo[d]isoxazole

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

Related Products of 374554-89-9, In heterogeneous catalysis, the catalyst is in a different phase from the reactants. At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way.374554-89-9, Name is 3-Chloro-6-fluorobenzo[d]isoxazole, molecular formula is C7H3ClFNO. In a Patent£¬once mentioned of 374554-89-9

Pharmaceutically useful pyrazolo[4,3-b]pyridines

A compound of the formula (I) or a salt or solvate thereof: STR1 in which: R0 is hydrogen or C1-6 alkyl; or together with R3 is C4-6 polymethylene; R1 and R2 are both hydrogen; or R1 is hydrogen, C1-6 alkyl; and R2 is CN; CR5 R6 Y where R5 and R6 are independently selected from hydrogen and C1-4 alkyl and Y is selected from hydrogen, OR7 or SR7 where R7 is hydrogen, C1-4 alkyl or C2-4 alkanoyl, and NR8 R9 where R8 and R9 are independently hydrogen, C1-4 alkyl, C2-4 alkenyl or C2-4 alkanoyl or together are C4-6 polymethylene; or COR10 where R10 is OH or C1-4 alkyl, or COR10 is a pharmaceutically acceptable ester or amide, or R2 is hydrogen, C1-6 alkyl, or phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl, and R1 is CN, CR5 R6 Y or COR10 as defined for R2 above; or R1 and R2 together form C3 -C6 polymethylene optionally substituted by C1 -C4 alkyl; R3 is hydrogen; or C1-10 alkyl or C3-10 cycloalkyl, either optionally substituted by hydroxy, C1-4 alkoxy, thiol, C1-4 alkylthio or NR11 R12 wherein R11 and R12 are independently hydrogen, C1-6 alkyl or C2-7 alkanoyl or together are C3-6 polymethylene; C2-10 alkenyl; or phenyl optionally substituted by one or two of halogen, CF3, C1-4 alkoxy, C1-4 alkyl, hydroxy, nitro, cyano, C2-10 acyloxy, NR13 R14 wherein R13 and R14 are independently selected from hydrogen, C1-6 alkyl, or C2-7 alkanoyl; or COR15 wherein R15 is hydroxy, C1-6 alkoxy or NR16 R17 wherein R16 and R17 are independently selected from hydrogen or C1-6 alkyl; or R3 is a mono- or fused bi-cyclic heteroaryl group having up to ten atoms in the aromatic ring(s), not more than two of which are selected from nitrogen, oxygen or sulphur, other than those containing basic nitrogen, optionally substituted by one or two substituents selected from halogen, CF3, C1-4 alkoxy, C1-4 alkyl, hydroxy, nitro, cyano, C2-10 acyloxy, NR23 R24 wherein R23 and R24 are independently selected from hydrogen, C1-6 alkyl, C2-7 alkanoyl or C1-6 alkylsulphonyl; or COR25 wherein R25 is hydroxy, C1-6 alkoxy or NR26 R27 wherein R26 and R27 are independently selected from hydrogen or C1-6 alkyl; R4 is hydrogen, or C1-4 alkyl, phenyl or benzyl, each of which is optionally substituted in the phenyl ring by one or two of halogen, CF3, C1-4 alkoxy or C1-4 alkyl and is attached at nitrogen atom 1 or 2; and Rx is C1-6 alkyl, halogen, nitro, NR18 R19 where R18 and R19 are independently hydrogen, C1-6 alkyl or C2-7 alkanoyl, nitrile, COOH, CONH2 ; phenyl or benzyl optionally substituted by one or two of halogen, nitro, C1-6 alkoxy, hydroxy, C2-7 alkanoyloxy, NR18 R19, C1-6 alkyl, CF3, CN; thienyl, furyl or pyrryl optinoally N-substituted by C1-6 alkyl, with the proviso that R0 and R3 are not both hydrogen when R1 is hydrogen and R2 and Rx are methyl, is useful for treating inflammatory or allergic conditions.

Related Products of 374554-89-9, Interested yet? Read on for other articles about Related Products of 374554-89-9!

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

Reference of 374554-89-9, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 374554-89-9, 3-Chloro-6-fluorobenzo[d]isoxazole, introducing its new discovery.

5- And/or 7-substituted pyrazolo-[4,3-b]-pyridines and their use as antiinflammatory agents

Compounds of the formula (I) and pharmaceutically acceptable salts thereof: STR1 wherein: the first of R1 and R2 is hydrogen, C1-4 alkyl or phenyl optionally substituted by one or two substituents selected from halogen, CF3, C1-4 alkoxy or alkyl and the second is SR4 wherein R4 is phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl, or NR5 R6 wherein R5 and R6 are independently selected from hydrogen, C1-6 alkyl, C3-8 cycloalkyl, phenyl or phenyl C1-4 alkyl either of which phenyl moieties may be substituted by one or two substituents selected from halogen, CF3, C1-4 alkoxy or C1-4 alkyl, or R5 and R6 together form C4-6 polymethylene; and R3 is hydrogen, C1-4 alkyl or benzyl and is attached at nitrogen atom 1 or 2, having anti-inflammatory activity, a process for their preparation and their use as pharmaceuticals.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Reference of 374554-89-9, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about Reference of 374554-89-9

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics

Electric Literature of 374554-89-9, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 374554-89-9, 3-Chloro-6-fluorobenzo[d]isoxazole, introducing its new discovery.

Certain anti-inflammatory pyrazolo [4,3-b] pyridine 7-amines

A compound of the formula (1) or a salt or solvate thereof: STR1 in which: R0 is hydrogen or C1-6 alkyl; R1 and R2 are both hydrogen; or R1 is hydrogen, C1-6 alkyl; and R2 is CN; CR5 R6 Y where R5 and R6 are independently selected from hydrogen and C1-4 alkyl and Y is selected from hydrogen, OR7 or SR7 where R7 is hydrogen, C1-4 alkyl or C2-4 alkanoyl, and NR8 R9 where R8 and R9 are independently hydrogen, C1-4 alkyl, C2-4 alkenyl or C2-4 alkanoyl or together are C4-6 polymethylene; or COR10 is OH or C1-4 alkyl, or COR10 is a pharmaceutically acceptable ester or amide; or R2 is hydrogen, C1-6 alkyl, or phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl; and R1 is CN, CR5 R6 Y or COR10 as defined for R2 above; or R1 and R2 together form C3 -C6 polymethylene optionally substituted by C1 -C4 alkyl; R3 is –(CH2)n CO2 R11, –(CH2)n CONR12 R13,–(CH2)n CN, –(CH2)m NHCOR14, STR2 where a, b, n, m and p are integers and n is 1 to 10, m is 2 to 10, p is 3 to 5, a is 1 to 3, and b is 1 to 3, and R11 is hydrogen, C1-8 alkyl, benzyl or phenyl, R12 and R13 are independently hydrogen, C1-6 alkyl, benzyl or phenyl, or together form C3-8 alkylene, R14 is C1-4 alkyl, benzyl or phenyl and X is oxygen, sulphur, NH or N–C1-4 alkyl, and R4 is hydrogen; or C1-4 alkyl or benzyl optionally substituted in the phenyl ring by one or two of halogen, CF3, C1-4 alkoxy or C1-4 alkyl, and is attached at nitrogen atom 1 or 2, a process for its preparation and its use as a pharmaceutical.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Electric Literature of 374554-89-9, you can also check out more blogs aboutElectric Literature of 374554-89-9

Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics